Related Experiment Video
Updated: May 26, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Workshop summary: Novel biomarkers for HIV incidence assay development
Usha K Sharma1, Marco Schito, Alex Welte
1Prevention Sciences Program (PSP), Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-7628, USA. usharma@niaid.nih.gov
Accurate human immunodeficiency virus (HIV) incidence assays are crucial for evaluating prevention strategies and trials. A workshop convened experts to discuss developing next-generation HIV incidence assays for rapid, cost-efficient measurement.
Area of Science:
- Virology
- Epidemiology
- Biomarker Discovery
Background:
- Reliable human immunodeficiency virus (HIV) incidence measurement is critical for effective HIV prevention strategies and trials.
- Current methods for distinguishing recent from chronic HIV infections require improvement in accuracy, speed, and cost-efficiency.
- There is an urgent need for new incidence assays utilizing easily obtainable specimens.
More Related Videos
08:37Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011